We will get a conditional eGFR at circa week 70 (maybe mid Nov 24 ?), is how I see it - snippet below from Dimerix Website. But if Part 2 is positive, we have the potential to submit for a fast-tracked regulatorypathway to approval given the Orphan Drug Designation for DMX-200 in both the US and Europe for FSGS.
We will get a conditional eGFR at circa week 70 (maybe mid Nov...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.005(1.06%) |
Mkt cap ! $255.8M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 48.5¢ | 46.5¢ | $1.514M | 3.204M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 121059 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 106197 | 4 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |